Welcome to Sagentia at AACC 2020
Who are we and what do we do? Sagentia is a R&D Consultancy with a 30-year history delivering innovative diagnostic platforms to our international partners. We blend scientific first principles and human factors to augment our cartridge-led development and are privileged to have developed the first CLIA waived molecular Dx cartridge in 2015. We believe that understanding the user in consideration with technical excellence and commercial viability is the key to improving patient outcomes and employ over 150 scientists, engineers and design thinkers to enable this.
We benefit our partners through:
- A user centred, cartridge-led approach that accelerates your timelines
- In-house prototyping to rapidly de-risk and iterate your microfluidic platform
- Access to industry expert diagnostic developers to extend your team
- Turn-key ISO:13485 development solutions
Contact us to find out more
Watch our talk at AACC “Getting your new assay to point of care – optimizing consumable and instrument design”
Outline of the talk
Nick Collier and Steve Brown share top 9 learnings from many PoC diagnostic assay development projects. They will highlight some key considerations, things to avoid and where the focuses should be to ensured getting to marketing faster and at the right price point.